v3.23.3
Revenue
 6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Revenue from Contract with Customer [Abstract]    
Revenue

5. Revenue

 

We generate revenue primarily through the sales of our licensed products Ameluz®, BF-RhodoLED® lamps and Xepi®. Revenue from the sales of our BF-RhodoLED® lamp and Xepi® are relatively insignificant compared with the revenues generated through our sales of Ameluz®.

 

Related party revenue relates to an agreement with Biofrontera Bioscience GmbH (“Bioscience”) for BF-RhodoLED® leasing and installation service. Refer to Note 13, Related Party Transactions.

 

An analysis of the changes in product revenue allowances and reserves is summarized as follows:

 

(in thousands):  Returns   Co-pay assistance program   Prompt pay discounts   Government and payor rebates   Total 
Balance at December 31, 2021  $43   $101   $48   $54   $246 
Provision related to current period sales   5    380    11    129    525 
Credit or payments made during the period   (5)   (300)   (20)   (115)   (440)
Balance at June 30, 2022  $43   $181   $39   $68   $331 
                          
Balance at December 31, 2022  $48   $9   $5   $20   $82 
                          
Provision related to current period sales   3    62    3    134    202 
Credit or payments made during the period   -    (71)   (2)   (59)   (132)
Balance at June 30, 2023  $51    -    6    95    152 

 

5. Revenue

 

We generate revenue primarily through the sales of our products Ameluz®, BF-RhodoLED® lamps and Xepi®. Revenue from the sales of our BF-RhodoLED® lamp and Xepi® are relatively insignificant compared with the revenues generated through our sales of Ameluz®.

 

Related party revenue relates to an agreement with Biofrontera Bioscience GmbH (“Bioscience”) for BF-RhodoLED® leasing and installation service. Refer to Note 17, Related Party Transactions.

 

An analysis of the changes in product revenue allowances and reserves is summarized as follows:

 

       Co-pay   Prompt   Government     
       assistance   pay   and payor     
(in thousands):  Returns   program   discounts   rebates   Total 
Balance at December 31, 2020  $217   $52   $15   $43   $327 
Provision related to current period sales   6                 423                40    168    637 
Credit or payments made during the period   (180)   (374)   (7)   (157)   (718)
Balance at December 31, 2021  $        43   $101   $48   $              54   $246 
Provision related to current period sales   10    574    19    210    813 
Credit or payments made during the period   (5)   (666)   (62)   (244)   (977)
Balance at December 31, 2022  $48   $9   $

5

   $20   $82